Pacer Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-718
| Closed | -$29.5K | – | 2642 |
|
|
2024
Q2 | $29.5K | Sell |
718
-122
| -15% | -$5.01K | ﹤0.01% | 3326 |
|
|
2024
Q1 | $39.2K | Buy |
+840
| New | +$39.2K | ﹤0.01% | 3267 |
|
|
2021
Q2 | – | Sell |
-609
| Closed | -$69K | – | 1526 |
|
|
2021
Q1 | $69K | Sell |
609
-296
| -33% | -$33.5K | ﹤0.01% | 1384 |
|
|
2020
Q4 | $125K | Sell |
905
-638
| -41% | -$88.1K | ﹤0.01% | 1329 |
|
|
2020
Q3 | $127K | Buy |
+1,543
| New | +$127K | ﹤0.01% | 1226 |
|
|
2018
Q4 | – | Sell |
-2,910
| Closed | -$222K | – | 933 |
|
|
2018
Q3 | $222K | Buy |
+2,910
| New | +$222K | 0.01% | 1013 |
|
|
2018
Q1 | – | Sell |
-1,100
| Closed | -$51K | – | 1110 |
|
|
2017
Q4 | $51K | Buy |
+1,100
| New | +$51K | ﹤0.01% | 1009 |
|
|
2017
Q3 | – | Sell |
-3,402
| Closed | -$211K | – | 1242 |
|
|
2017
Q2 | $211K | Buy |
3,402
+365
| +12% | +$22.6K | 0.02% | 984 |
|
|
2017
Q1 | $206K | Buy |
3,037
+560
| +23% | +$38K | 0.03% | 905 |
|
|
2016
Q4 | $174K | Buy |
2,477
+240
| +11% | +$16.9K | 0.02% | 914 |
|
|
2016
Q3 | $159K | Buy |
2,237
+192
| +9% | +$13.6K | 0.02% | 900 |
|
|
2016
Q2 | $100K | Buy |
+2,045
| New | +$100K | 0.02% | 987 |
|